MLICM
VXRT

Metropolitan Life Insurance Company (MetLife)’s Vaxart VXRT Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-8,060
Closed -$7.75K – 2472
2022
Q4 		$7.75K Buy
8,060
+535
+7% +$756 ﹤0.01% 2333
2022
Q3 		$16.4K Buy
7,525
+2,306
+44% +$7.95K ﹤0.01% 2119
2022
Q2 		$18.3K Sell
5,219
-2,995
-36% -$11.2K ﹤0.01% 2085
2022
Q1 		$41.4K Sell
8,214
-17,604
-68% -$89.2K ﹤0.01% 1705
2021
Q4 		$162K Sell
25,818
-877
-3% -$5.99K ﹤0.01% 2165
2021
Q3 		$212K Sell
26,695
-7,558
-22% -$62.2K ﹤0.01% 2021
2021
Q2 		$257K Buy
34,253
+20,008
+140% +$140K ﹤0.01% 1973
2021
Q1 		$86.2K Sell
14,245
-2,486
-15% -$19.1K ﹤0.01% 2465
2020
Q4 		$95.5K Buy
16,731
+1,123
+7% +$7.14K ﹤0.01% 2378
2020
Q3 		$104K Buy
15,608
+222
+1% +$1.98K ﹤0.01% 2197
2020
Q2 		$136K Buy
+15,386
New +$44.2K ﹤0.01% 2066

Other funds holding VXRT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s VXRT Position: Q1 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Vaxart (VXRT) in Q1 2023, closing a stake of 8,060 shares — an estimated $7.75K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in VXRT in Q2 2020 and held it in 11 quarters. The position peaked at $257K in Q2 2021. 109 funds tracked by Wall St. Rank hold VXRT as of Q1 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Vaxart position as of Q1 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 8,060 Vaxart shares in Q1 2023, an estimated $7.75K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Vaxart in Q2 2020 and held it in 11 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Vaxart position peaked at $257K in Q2 2021.
  • 109 funds tracked by Wall St. Rank held Vaxart as of Q1 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2023, filed 15 May 2023.